Early health economic assessment of eLi ₁₂ , a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hours

Ole Kohler-Forsberg; Thea K. Kjær; Andrew A. Nierenberg; Tom Bschor; Lars V. Kessing; Christian L. Kraft; Lars Holger Ehlers

doi:10.1017/neu.2026.10071

April 6, 2026Acta NeuropsychiatricaOpen Access

Early health economic assessment of eLi ₁₂ , a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hours

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to assess the health economic potential of eLi12 for estimating 12-hour lithium levels when blood sampling deviates.
Conducted an early health economic assessment of eLi12.
Evaluated its potential for healthcare savings.
Guided investment decisions related to clinical implementation.
Identified significant healthcare savings from using eLi12.
Highlighted the importance of studying its clinical implementation.

Implication

Early economic evaluation of eLi12 estimates lithium levels, emphasizing potential healthcare savings.

Abstract

EEE can evaluate the health economic potential of new innovative methods, supporting early investment decisions and guiding research. eLi₁₂ can have significant healthcare savings, emphasizing the relevance of studying clinical implementation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kohler-Forsberg et al. (2026) studied this question.

synapsesocial.com/papers/69d5f05d74eaea4b11a79bbc https://doi.org/10.1017/neu.2026.10071

View Full Paper

Ask AI

Bookmark

Share

Early health economic assessment of eLi ₁₂ , a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hours

Key Points

Implication

Abstract

Discussion

Cite This Study

Early health economic assessment of eLi ₁₂ , a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hours

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading